4//SEC Filing
Bausch Christoph Lawrence 4
Accession 0001209191-22-050082
CIK 0001833214other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:45 PM ET
Size
5.7 KB
Accession
0001209191-22-050082
Insider Transaction Report
Form 4
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-13+274,875→ 274,875 totalExercise: $0.71Exp: 2032-09-13→ Common Stock (274,875 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889981
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:45 PM ET
- Size
- 5.7 KB